These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 19401880

  • 1. 24-hour intraocular pressure and blood pressure levels with latanoprost/timolol fixed combination versus timolol.
    Konstas AG, Pikilidou MI, Tsironi S, Mikropoulos D, Kozobolis VP, Sarafidis PA, Lasaridis AN, Nelson LA, Stewart WC.
    Curr Eye Res; 2009 May; 34(5):369-77. PubMed ID: 19401880
    [Abstract] [Full Text] [Related]

  • 2. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.
    Quaranta L, Gandolfo F, Turano R, Rovida F, Pizzolante T, Musig A, Gandolfo E.
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2917-23. PubMed ID: 16799034
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Kałuzny J, Sobecki R, Czechowicz-Janicka K, Kecik D, Kałuzny BJ, Stewart JA, Stewart WC.
    Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.
    Rossetti L, Karabatsas CH, Topouzis F, Vetrugno M, Centofanti M, Boehm A, Viswanathan A, Vorwerk C, Goldblum D.
    Ophthalmology; 2007 Dec; 114(12):2244-51. PubMed ID: 17459480
    [Abstract] [Full Text] [Related]

  • 5. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
    Stewart WC, Konstas AG, Nelson LA, Kruft B.
    Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
    [Abstract] [Full Text] [Related]

  • 6. Effects of the timolol-dorzolamide fixed combination and latanoprost on circadian diastolic ocular perfusion pressure in glaucoma.
    Quaranta L, Miglior S, Floriani I, Pizzolante T, Konstas AG.
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4226-31. PubMed ID: 18502991
    [Abstract] [Full Text] [Related]

  • 7. A 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual components.
    Diestelhorst M, Larsson LI, European-Canadian Latanoprost Fixed Combination Study Group.
    Ophthalmology; 2006 Jan; 113(1):70-6. PubMed ID: 16263174
    [Abstract] [Full Text] [Related]

  • 8. Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy.
    Liu JH, Medeiros FA, Slight JR, Weinreb RN.
    Ophthalmology; 2009 Mar; 116(3):449-54. PubMed ID: 19157559
    [Abstract] [Full Text] [Related]

  • 9. A comparison of the effects of dorzolamide/timolol fixed combination versus latanoprost on intraocular pressure and pulsatile ocular blood flow in primary open-angle glaucoma patients.
    Janulevicienë I, Harris A, Kagemann L, Siesky B, McCranor L.
    Acta Ophthalmol Scand; 2004 Dec; 82(6):730-7. PubMed ID: 15606472
    [Abstract] [Full Text] [Related]

  • 10. Dorzolamide/timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Cvenkel B, Stewart JA, Nelson LA, Stewart WC.
    Curr Eye Res; 2008 Feb; 33(2):163-8. PubMed ID: 18293187
    [Abstract] [Full Text] [Related]

  • 11. Twenty-four-hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination.
    Konstas AG, Papapanos P, Tersis I, Houliara D, Stewart WC.
    Ophthalmology; 2003 Jul; 110(7):1357-60. PubMed ID: 12867391
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy.
    Stewart WC, Stewart JA, Day DG, Sharpe ED, Jenkins JN.
    Eye (Lond); 2004 Oct; 18(10):990-5. PubMed ID: 15037890
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A comparison of the fixed combination of latanoprost and timolol with its individual components.
    Pfeiffer N, European Latanoprost Fixed Combination Study Group.
    Graefes Arch Clin Exp Ophthalmol; 2002 Nov; 240(11):893-9. PubMed ID: 12486510
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.